Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trialCaicun Zhou, Jianjun Zou, Jianhua Shi et al.|The Lancet Respiratory Medicine|2020Cited by 504
Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer modelTao Yin, Yongsheng Wang|Molecular Medicine Reports|2015Cited by 53
Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung AdenocarcinomaHongjin Chen, Yongsheng Wang|Frontiers in Oncology|2021Cited by 31
Continuous exposure of non-small cell lung cancer cells with wild-type EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activating STAT3Jie Tang, Yongsheng Wang|International Journal of Oncology|2015Cited by 27